Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice

Neoplasia

Volumn 9, Issue 5, 2007, Pages 401-405

  Yan, Ying ^a   Cook, Julie ^a   McQuillan, Jay ^a   Zhang, Guifang ^b   Hitzman, Cory J ^b,c   Wang, Yian ^a   Wiedmann, Timothy S ^b   You, Ming ^a  

^a USA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Boston Scientific Inc   (United States)

Author keywords

Aerosol; Chemoprevention; Lung tumorigenesis; Mouse; Polyphenon E

Indexed keywords

EPIGALLOCATECHIN GALLATE; POLYPHENOL DERIVATIVE; POLYPHENON E; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER REGRESSION; CANCER RISK; CANCER SIZE; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; INHALATION; LUNG CARCINOGENESIS; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34249002243     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07160     Document Type: Article

References (27)

1. Minna JD, Roth JA, and Gazdar AF (2002). Focus on lung cancer. Cancer Cell 1, 49-52.
2. Tatsumura T, Koyama S, Tsujimoto M, Kitagawa M, and Kagamimori S (1993). Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br J Cancer 68, 1146-1149.
3. Verschraegen CF, Gilbert BE, Loyer E, Huaringa A, Walsh G, Newman RA, and Knight V (2004). Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 10, 2319-2326.
4. Rao RD, Markovic SN, and Anderson PM (2003). Aerosol therapy for malignancy involving the lungs. Curr Cancer Drug Targets 3, 239-250.
5. Kim HW, Park IK, Cho CS, Lee KH, Beck GR Jr, Colburn NH, and Cho MH (2004). Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 64, 7971-7976.
6. Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, and Wattenberg LW (2004). Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice. Carcinogenesis 25, 197-201.
7. Gautam A and Koshkina N (2003). Paclitaxel (Taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery. Curr Cancer Drug Targets 3, 287-296.
8. Koshkina NV, Waldrep JC, and Knight V (2003). Camptothecins and lung cancer: improved delivery systems by aerosol. Curr Cancer Drug Targets 3, 251-264.
9. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, and Kelloff GJ (1997). Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 57, 5489-5492.
10. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE, and Kelloff GJ (2000). Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 21, 179-182.
11. Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, Anderson MW, Wiseman RW, Lubet RA, and You M (2000). A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents Taxol or adriamycin. Cancer Res 60, 901-907.
12. Liao J, Yang GY, Park ES, Meng X, Sun Y, Jia D, Seril DN, and Yang CS (2004). Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 48, 44-53.
13. Mimoto J, Kiura K, Matsuo K, Yoshino T, Takata I, Ueoka H, Kataoka M, and Harada M (2000). (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis 21, 915-919.
14. Wang ZY, Huang MT, Ho CT, Chang R, Ma W, Ferraro T, Reuhl KR, Yang CS, and Conney AH (1992). Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 52, 6657-6665.
15. Gupta S, Hastak K, Ahmad N, Lewin JS, and Mukhtar H (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98, 10350-10355.
16. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, and Fujiki H (1995). Inhibition of N-methyl-N′-nitro- N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55, 2081-2084.
17. Chang PY, Mirsalis J, Riccio ES, Bakke JP, Lee PS, Shimon J, Phillips S, Fairchild D, Hara Y, and Crowell JA (2003). Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E. Environ Mol Mutagen 41, 43-54.
18. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, and Weinstein IB (2005). (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11, 2735-2746.
19. Hirose M, Mizoguchi Y, Yaono M, Tanaka H, Yamaguchi T, and Shirai T (1997). Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene. Cancer Lett 112, 141-147.
20. Zhang Z, Wang Y, Yao R, Li J, Yan Y, La Regina M, Lemon WL, Grubbs CJ, Lubet RA, and You M (2004). Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models. Oncogene 23, 3841-3850.
21. Liao X, Liang W, Wiedmann T, Wattenberg L, and Dahl A (2004). Lung distribution of the chemopreventive agent difluoromethylornithine (DFMO) following oral and inhalation delivery. Exp Lung Res 30, 755-769.
22. Wiedmann TS and Hitzman CJ (2004). Reflux drying of aerosols. J Aerosol Med 17, 344-353.
23. Yang CS, Yang GY, Landau JM, Kim S, and Liao J (1998). Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp Lung Res 24, 629-639.
24. Cao J, Xu Y, Chen J, and Klaunig JE (1996). Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam Appl Toxicol 29, 244-250.
25. Wang ZY, Hong JY, Huang MT, Reuhl KR, Conney AH, and Yang CS (1992). Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52, 1943-1947.
26. You M and Bergman G (1998). Preclinical and clinical models of lung cancer chemoprevention. Hematol/Oncol Clin North Am 12, 1037-1053.
27. Yang CS, Chung JY, Yang GY, Li C, Meng X, and Lee MJ (2000). Mechanisms of inhibition of carcinogenesis by tea. Biofactors 13, 73-79.